Literature DB >> 14757417

A large animal noninjury model for study of human stem cell plasticity.

Graça Almeida-Porada1, Esmail D Zanjani.   

Abstract

In this paper, we describe an experimental model that allows evaluation of the full potential of stem cells under normal physiological conditions and in the absence of genetic or injury-induced dysfunction, thus serving as a valuable tool for the study of the mechanism(s) underlying stem cell differentiation. The fetal sheep model of human stem cell transplantation permits the robust formation of donor-derived tissue-specific cells in the absence of selective pressure given its unique characteristics: the preimmune status of the fetus allows donor stem cell engraftment without significant rejection and the existence of the naturally occurring migratory patterns in the fetus facilitates the widespread efficient distribution of donor stem cells throughout the body. The cells are then influenced by the stimulatory environment of the specific tissue or organ to undergo proliferation and directed differentiation. The versatility of this noninjury fetal model of human stem cell plasticity was demonstrated by revealing the differentiative potential of different populations of both human hematopoietic stem cells and human mesenchymal stem cells (MSC).

Entities:  

Mesh:

Year:  2004        PMID: 14757417     DOI: 10.1016/j.bcmd.2003.09.018

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  11 in total

Review 1.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

2.  Depletion of murine fetal hematopoietic stem cells with c-Kit receptor and CD47 blockade improves neonatal engraftment.

Authors:  Russell G Witt; Bowen Wang; Quoc-Hung Nguyen; Carlo Eikani; Aras N Mattis; Tippi C MacKenzie
Journal:  Blood Adv       Date:  2018-12-26

3.  Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells.

Authors:  Russell G Witt; Emily M Kreger; Laura B Buckman; Patriss W Moradi; Phong T Ho; S Christopher Derderian; Perry Tsai; Chris Baker; Nathaniel Schramm; Rachel Cleary; J Victor Garcia; Tippi C MacKenzie
Journal:  Blood Adv       Date:  2018-01-05

4.  Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC.

Authors:  Christopher D Porada; Chad Sanada; Chung-Jung Kuo; Evan Colletti; Walter Mandeville; John Hasenau; Esmail D Zanjani; Robert Moot; Christopher Doering; H Trent Spencer; Graça Almeida-Porada
Journal:  Exp Hematol       Date:  2011-09-08       Impact factor: 3.084

Review 5.  Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  Adv Drug Deliv Rev       Date:  2010-09-07       Impact factor: 15.470

Review 6.  Bone marrow stem cells and liver regeneration.

Authors:  Graça Almeida-Porada; Esmail D Zanjani; Christopher D Porada
Journal:  Exp Hematol       Date:  2010-04-24       Impact factor: 3.084

7.  Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-25

Review 8.  Concepts for the clinical use of stem cells in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

9.  Mesenchymal stem cell-derived hepatocytes for functional liver replacement.

Authors:  Bruno Christ; Peggy Stock
Journal:  Front Immunol       Date:  2012-06-22       Impact factor: 8.786

Review 10.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.